Revolve Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,400
Closed -$3.18M 234
2025
Q2
$3.18M Buy
+11,400
New +$3.23M 0.41% 37

Other funds holding AMGN

Revolve Wealth Partners's AMGN Position: Q2 2026 in Review

Revolve Wealth Partners reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $124K and leaving 12,937 shares worth $4.68M. The position accounts for 0.49% of the portfolio, ranked #39.

Revolve Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.42M in Q4 2021. 1,292 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Revolve Wealth Partners held 12,937 shares of Amgen worth $4.68M as of Q2 2026.
  • Revolve Wealth Partners sold 361 Amgen shares in Q2 2026, an estimated $124K.
  • Amgen made up 0.49% of Revolve Wealth Partners's portfolio in Q2 2026, its #39 holding.
  • Revolve Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Revolve Wealth Partners's Amgen position peaked at $6.42M in Q4 2021.
  • 1,292 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.